Icade Santé, a 56.8%-owned subsidiary of Icade, has successfully completed its first €500mn bond issue maturing in 2029 at a fixed rate of 0.875%. This benchmark operation will enable Icade Santé to fund its expansion plan, which has set the goal of investing €1nn in France by 2022.
More than six times over-subscribed by major investors, it reflects their interest in the fundamentals of Icade Santé, the leading healthcare property investor in France with a portfolio of 115 institutions representing assets of €4.5bn as of 30 June 2019.
Two priorities for Icade Santé looking ahead to 2022:
- Strengthening its position as the number 1 healthcare property company in France in the clinic sector and continuing its diversification in the nursing home sector ;
- Asserting its international development in continental Europe and building a leading European platform in healthcare real estate.